Leopoldina Home Menü

Leopoldina Home

Lectures & Discussions

Expanding the Scope of CAR T Cell Therapy

More 'Expanding the Scope of CAR T Cell Therapy'

Image: Keith Chambers / Science Photo Library

Interdisciplinary Discussion

Date: Monday, 8 to Tuesday, 9 April 2024
Location: Leopoldina, Jägerberg 1, 06108 Halle (Saale) und Online

The onset of Chimeric Antigen Receptor (CAR) T cell therapy marks a revolutionary development in the field of immunotherapy, achieving notable success since its approval in 2017 for treating B cell malignan-cies. Designing a patient's own T cells to specifically identify and eradicate tumor cells has successfully treated individuals with previously incurable hematologic cancers.

While CAR T cells are currently predominantly utilized in anti-tumor therapy, their initial conceptualization aimed at a broader objective of targeting membrane antigens, opening the door to numerous potential applications. Subsequent studies have explored the application of CAR T cells in non-malignant pathologies, encompassing autoimmune diseases, infectious diseases, and more recently, conditions such as cardiac fibrosis and cellular senescence.

Within this interdisciplinary discussion, we present key findings and implications of CAR-based therapies for non-malignant conditions.


The event will be streamed under the section "Live" on the Leopoldina´s YouTube channel.

Further information and Registration

The interdisciplinary discussion is registered as an training event with the Saxony-Anhalt Medical Association and is aimed at a professionally interested public.

Registration is closed.


Dr. Stefanie Bohley
Department Science - Policy - Society
E-Mail: stefanie.bohley@leopoldina.org